You are on page 1of 8

INTERNSHIP 1 EXERCISE 1 GENERAL REQUIREMENTS FOR ISSUANCE OF LTO BY BFAD TERMS TO DEFINE REQUIREMENTS FOR OPENING A DRUGSTORE UNDER

TORE UNDER PREMISES REQUIREMENTS FOR OPENING A DRUGSTORE UNDER UTENSILS, APPARATUS, & EQUIPMENT rigerator BIO-REF REQUIREMENTS FOR RENEWAL OF LTO name, citizenship, picture, proposed area cert. of business name registration (BDT of DTI) cert. of registration (SEC) and articles of Incorporation or partnership REQUIREMENTS FOR DRUGSTORE/RETAIL OUTLET FOR NON-RX DRUGS ubber stamp of outlets -ID

floor plan with dimension Requirement

Petition Form Requirement Undertaking List of Tentative Products Example o Paracetamol Biogesic Tempra Tylenol Winadol Acetadol Rexidol License To Operate Pharmacist Pharmacist Pharmacist REFERENCE BOOKS RECORD BOOKS POISON/CHEMICAL BOOK OPIUM BOOK

certificate Pharmacist

Basis of Therapeutics

EXERCISE NO. 2 THE CONTROL OF PHARMACY PROFESSION Terms To Define ETHICS STATUTORY LAWS AFFECTING PHARMACY PROFESSION JUNE 22, 1969 JUNE 23, 1963 SEPT 4, 1996 1988 2002, repealing RA 6425 amending RA 7432 PRICE ACT CONSUMERS ACT THE PHARMACY LAW R.A. 5921 is an act regulating the practice of pharmacy and setting standards of pharmaceutical education in the Philippines and other purposes THE FOODS, DRUGS & DEVICES R.A. 3720 this is an act to ensure the safety and purity of foods and cosmetics, and the purity, safety, efficacy, and quality of drugs and devices being made available to the public vesting the BFAD with authority to administer and enforce the laws pertaining thereto SPECIAL LAW ON COUNTERFEIT DRUGS R.A. 8203 It is an act prohibiting counterfeit drugs, providing penalties for violations and appropriating funds. The BFAD of the Department of Health is authorized to administer and supervise the implementation of this Act which was approved on September 4, 1996. THE GENERICS ACT R.A. 6675 It is act to promote, require, and ensure the production of an adequate supply, distribution, use and acceptance of drugs and medicines identified by their generic names. COMPREHENSIVE DANGEROUS DRUG ACT R.A. 9165 It is an act instituting the Comprehensive Dangerous Drugs Act of 2002, repealing Republic Act No. 6425, otherwise known as the Dangerous Drugs Act of 1972 EXPANDED SENIOR CITIZEN ACT R.A. 9257 An act granting additional benefits and privileges to senior citizens amending for the purpose RA No. 7432, otherwise known as An act to maximize the contribution of senior citizens to nation building, grant benefits and special privileges and for other purposes THE PRICE ACT R.A. 7581 An act providing protection to consumers by stabilizing the prices of basic necessities and prime commodities and by prescribing measures against undue price increases during emergency situations and like occasions CONSUMERS ACT R.A. 7394 It is an act to protect the interest of the consumer, promote his general welfare and to establish standards of conduct for business and industry.

PRINCIPLES OF PROFESSIONAL CONDUCT Integrity and Objectivity CODE OF ETHICS responsibilities EXERCISE 3 THE COMMUNITY PHARMACY PROFILE

pharmacists roles and

-TRADITIONAL MARKET STORE FRONT LAYOUTS

WAYS OF DEVELOPING COMPETITIVE ADVANTAGES IN COMMUNITY PHARMACY /facilities COMPARISON OF COMMUNITY PHARMACY IN 1990S AND 2000S Mercury DrugStore BEING FIRST TO INTRODUCE 24 HOUR SERVICE BEING FIRST MOTORIZED CUSTOMER DELIVERY

BEING FIRST COMPUTERIZED TEMPERATURE CONTROLLED WAREHOUSE BEING FIRST COMMUNITY PHARMACY INSIDE SHOPPING MALLS AND SUPERMARKETS BEING FIRST MODERNIZE STORE FRONT, INTERIORS WAREHOUSE AND LAYOUT BEING FIRST MEDICAL-PHARMACY OUTREACH MISSION BEING FIRST DRUGSTORE CHAIN TO EXPAND THROUGHOUT BEING FIRST PROFESSIONALIZE ITS PERSONNEL

Exercise 4 THERAPEUTIC CATEGORIES OF DRUGS BY PNDF

THERAPEUTIC COMMITTEES

GENERAL GUIDELINES FOR ESTABLISHING PNDF workers at different levels of health care al health problems therapeutically equivalent drugs Criteria for inclusion of drugs into PNDF is needed for prevention and the of conditions not already covered in existing list drug listed for same medication for specific DOH health project Criteria for deletion of drugs from PNDF toxic drug becomes available unsatisfactory or questionable toxicity or potential for abuse or dangerous interactions outweigh its therapeutic value -effective to other therapies does not satisfy the requirements of AO 96 s. 1990

Core List Acetylcysteine Ergocalciferol Azathioprine Fluorecein Clofazimine Folic acid Cobra antivenin Hydrochlorthiazide Dantrolene Hydrocortisone Diazepam Hydroxycobalamine Diethylcarbamazepine Indomethacin inj Diphtheria-tetanus toxoids Iodine Dimercaprol INH + ethambutol endrophonium INH + rifampicin INH+ Rifampicin+ PZA Praziquantrel Levodopa + Thiacetazone Retinol Lorazepam Na Ca edetate Methylene blue NaI 131I N-acetyl penicillamine Na nitrite Neostigmine Na nitroprusside Nicotinamide Na thiosulfate ORS 75 replacement Succimer Potassium Thiamine Pot. phosphate Tuberculin purified protein

Complementary List Aciclovir eye ointment Hydroxycobalamin Alpha-tocopherol Indomethacin Al acetate Iodamide Cromolyn Iron dextran Buserelin Povidone iodide Busulfan Pralidoxime Cl Chloral hydrate Pyrimethamine Chlormethine Recombinant tissue plasminogen activator Dithranol Rifabutin estramustine Rose bengal Silver nitrate Varicella zoster Ig Spectinomycin Vasopressin Terizodone Yerba buena Tetracosactide Zinc Thiacetazone Drugs in PNDF with special requirements o Alprazolam o Morphine o Bromazepam o Nalbuphine o Butorphanol o Oxycodone o Clonazepam o Pethidine (meperidine) o Codein o Phenobarbital Diazepam o Thiopenthal Na Fentanyl o Tramadol o Lorazepam o Zolpidem o Methylphenidate midazolam chemicals (A2) o o o

Medicinal products listed with BFAD

You might also like